Isosorbidmononitrat Ismn Retard Pro Al (Isosorbide Mononitrate)

Isosorbide mononitrate is converted in the body to nitric oxide, a potent vasodilator. Nitric oxide activates guanylate cyclase, raising cyclic GMP levels in vascular smooth muscle. This causes relaxation of arteries and veins, lowering cardiac preload and afterload, and increasing oxygen delivery to the myocardium.

The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. Physicians typically start with a low dose and may adjust it gradually to achieve optimal symptom control while monitoring for side effects.

Safety data for isosorbide mononitrate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Healthcare providers should weigh potential benefits against possible risks before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Isosorbide mononitrate belongs to the nitrate class, offering a longer‑acting oral option compared with short‑acting nitroglycerin. Unlike beta‑blockers or calcium‑channel blockers, nitrates primarily reduce cardiac preload and afterload through vasodilation, making them useful for patients who need additional symptom control or cannot tolerate other classes.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture, heat, and direct sunlight. Do not refrigerate or freeze the product, and ensure the packaging remains sealed until use.

The medication is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and whether the dose should be taken in the morning or evening to minimise side effects.

The most serious risks include severe hypotension, syncope, and rare allergic reactions that may present as rash, swelling, or breathing difficulty. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, or any signs of an allergic response.

Individuals with known hypersensitivity to isosorbide mononitrate or other nitrates should avoid this medication. It is also contraindicated in patients taking phosphodiesterase‑5 inhibitors, those with severe anemia, or patients with uncontrolled hypotension. Clinicians must assess each patient’s medical history before prescribing.